ATHE Alterity Therapeutics Limited

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-163

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of September 2023

 

Alterity Therapeutics Limited

(Name of Registrant)

 

Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia

(Address of Principal Executive Office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F  ☒       Form 40-F  ☐

 

This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and our Registration Statements on Form F-3 (Files No. 333-251647, 333-249311, 333-231417 and 333-250076)

 

 

 

ALTERITY THERAPEUTICS LIMITED

(a development stage enterprise)

 

The following exhibits are submitted:

 

99.1

Notification of cessation of securities – ATH

  

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	Alterity Therapeutics Limited
	/s/ Geoffrey P. Kempler
	By:	Geoffrey P. Kempler
		Chairman

 

Date: september 13, 2023

 

 

2

Exhibit 99.1

 

Notification of cessation of +securities

 

Announcement Summary

 

Entity name

 

ALTERITY THERAPEUTICS LIMITED

 

Announcement Type

 

New announcement

 

Date of this announcement

 

Wednesday September 13, 2023

 

Details of +securities that have ceased

 

ASX+security code		Security description		Number of +securities that have ceased		The +securities have ceased due to		Date of cessation
ATHAAG		OPTION EXPIRING 29-NOV-2026 EX $0.0238		500,000		Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied		11/09/2023

 

Refer to next page for full details of the announcement

 

 

Notification of cessation of +securities

 

Part 1 - Announcement Details

 

1.1 Name of +Entity

 

ALTERITY THERAPEUTICS LIMITED

 

We (the entity named above) provide the following information about our issued capital.

 

	1.2 Registered Number Type		Registration Number
	ABN		37080699065

 

1.3 ASX issuer code

 

ATH

 

1.4 The announcement is

 

þ New announcement

 

1.5 Date of this announcement

 

13/9/2023

 

 

Notification of cessation of +securities

 

Part 2 - Details of +equity securities or +debt securities that have ceased

 

ASX +Security Code and Description

 

ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238

 

Unquoted +equity securities that have ceased

 

Number of securities that have ceased

 

500,000

 

Reason for cessation

 

Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied

 

	Date of cessation		Is the entity paying any consideration for the cessation?
	11/9/2023		þ No

 

Any other information the entity wishes to notify to ASX about the cessation?

 

 

 

Notification of cessation of +securities

 

Part 3 - Issued capital following changes

 

Following the cessation of the + securities the subject of this notification, the issued capital of the entity will comprise:

 

3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)

 

ASX +security code and description			Total number of +securities on issue
ATH : ORDINARY FULLY PAID			2,439,897,618

 

3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)

 

ASX +security code and description		Total number of +securities on issue
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375			19,250,000
ATHAAF : OPTION EXPIRING 31-JUL-2024 EX $0.07			12,000,000
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238			11,900,000
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09			35,000,000
ATHAAC : OPTION EXPIRING 23-NOV-2023 EX $0.07			674,694,939
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032			91,392,720

 

Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

 

---